Blood pressure

Summarizes clinical trial evidence suggesting a possible link between angiotensin receptor blocker use and cancer, additional clinical evidence tending to refute a link, basic science evidence, and recent information about the problem of potentially cancer-causing impurities found in some angiotensin receptor blocker products.

We review the recent guidelines addressing the diagnosis and management of hypertension.

Editorial page describing our journal's strengthened ties with the British and Irish Hypertension Society.

Proposes a framework for thinking about pragmatic, one-size-fits-most treatment and highly personalized treatment of hypertension.

**Context:** Many antihypertensive medications modulate the renin-angiotensin-aldosterone system, possibly skewing the diagnosis and subtyping of primary aldosteronism (PA). Particularly, mineralocorticoid receptor antagonists (MRA) might raise renin …

We explain the approach to out-of-office blood pressure monitoring in 2018.

This patient page explains the use of 24-hour ambulatory blood pressure monitoring.

This study aims to evaluate the 4 non- pharmacological strategies adopted by patients for hypertension control and patient characteristics that affect the choice of strategies. Four thousand hypertensive patients aged ???18 years were selected from …